553 related articles for article (PubMed ID: 31811667)
21. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
22. Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.
Chen X; Subleski JJ; Hamano R; Howard OM; Wiltrout RH; Oppenheim JJ
Eur J Immunol; 2010 Apr; 40(4):1099-106. PubMed ID: 20127680
[TBL] [Abstract][Full Text] [Related]
23. Aberrant peripheral blood CD4
Dehghani M; Kalani M; Golmoghaddam H; Ramzi M; Arandi N
Cancer Immunol Immunother; 2020 Sep; 69(9):1917-1928. PubMed ID: 32385519
[TBL] [Abstract][Full Text] [Related]
24. T follicular helper cell-mediated IL-21 production suppresses FOXP3 expression of T follicular regulatory-like cells in diffuse large B cell lymphoma patients.
Ma X; Zha J; He J; Chen L; Huang J; Wu W; Tian P; Qian BH; Yu L; Jiang Y; Xu B
Hum Immunol; 2020 Aug; 81(8):452-459. PubMed ID: 32534760
[TBL] [Abstract][Full Text] [Related]
25. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
26. CD25-expressing Th17 cells mediate CD8
Lang C; Wang J; Chen L
Exp Cell Res; 2017 Nov; 360(2):384-389. PubMed ID: 28942020
[TBL] [Abstract][Full Text] [Related]
27. LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.
Camisaschi C; Casati C; Rini F; Perego M; De Filippo A; Triebel F; Parmiani G; Belli F; Rivoltini L; Castelli C
J Immunol; 2010 Jun; 184(11):6545-51. PubMed ID: 20421648
[TBL] [Abstract][Full Text] [Related]
28. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.
Santner-Nanan B; Peek MJ; Khanam R; Richarts L; Zhu E; Fazekas de St Groth B; Nanan R
J Immunol; 2009 Dec; 183(11):7023-30. PubMed ID: 19915051
[TBL] [Abstract][Full Text] [Related]
29. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
Strauss L; Bergmann C; Whiteside TL
Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
[TBL] [Abstract][Full Text] [Related]
30. CD26: a negative selection marker for human Treg cells.
Salgado FJ; Pérez-Díaz A; Villanueva NM; Lamas O; Arias P; Nogueira M
Cytometry A; 2012 Oct; 81(10):843-55. PubMed ID: 22949266
[TBL] [Abstract][Full Text] [Related]
31. Multiple sclerosis patients have reduced resting and increased activated CD4
Verma ND; Lam AD; Chiu C; Tran GT; Hall BM; Hodgkinson SJ
Sci Rep; 2021 May; 11(1):10476. PubMed ID: 34006899
[TBL] [Abstract][Full Text] [Related]
32. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
Hamza E; Gerber V; Steinbach F; Marti E
Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
[TBL] [Abstract][Full Text] [Related]
33. Maternal Foxp3 expressing CD4+ CD25+ and CD4+ CD25- regulatory T-cell populations are enriched in human early normal pregnancy decidua: a phenotypic study of paired decidual and peripheral blood samples.
Dimova T; Nagaeva O; Stenqvist AC; Hedlund M; Kjellberg L; Strand M; Dehlin E; Mincheva-Nilsson L
Am J Reprod Immunol; 2011 Jul; 66 Suppl 1():44-56. PubMed ID: 21726337
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast.
Jamiyan T; Kuroda H; Yamaguchi R; Nakazato Y; Noda S; Onozaki M; Abe A; Hayashi M
Breast Cancer; 2020 Sep; 27(5):880-892. PubMed ID: 32222891
[TBL] [Abstract][Full Text] [Related]
35. Identification of CD4+CD25 high Foxp3+ T cells in ovine peripheral blood.
Rocchi MS; Wattegedera SR; Frew D; Entrican G; Huntley JF; McNeilly TN
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):172-7. PubMed ID: 21831456
[TBL] [Abstract][Full Text] [Related]
36. Induction of antigen specific CD4(+)CD25(+)Foxp3(+)T regulatory cells from naïve natural thymic derived T regulatory cells.
Hall BM; Tran GT; Robinson CM; Hodgkinson SJ
Int Immunopharmacol; 2015 Oct; 28(2):875-86. PubMed ID: 25882104
[TBL] [Abstract][Full Text] [Related]
37. Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer.
Maruyama T; Kono K; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Izawa S; Fujii H
Cancer Sci; 2010 Sep; 101(9):1947-54. PubMed ID: 20550524
[TBL] [Abstract][Full Text] [Related]
38. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
[TBL] [Abstract][Full Text] [Related]
39. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.
Preston CC; Maurer MJ; Oberg AL; Visscher DW; Kalli KR; Hartmann LC; Goode EL; Knutson KL
PLoS One; 2013; 8(11):e80063. PubMed ID: 24244610
[TBL] [Abstract][Full Text] [Related]
40. Foxp3 expression in CD4
Zhu XW; Zhu HZ; Zhu YQ; Feng MH; Qi J; Chen ZF
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):677-682. PubMed ID: 27752897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]